$221 Million is the total value of Endurant Capital Management LP's 51 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 79.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SNY | New | SANOFIsponsored adr | $17,923,000 | – | 409,961 | +100.0% | 8.12% | – |
| PFE | New | PFIZER INC | $16,651,000 | – | 510,150 | +100.0% | 7.55% | – |
| HOLX | New | HOLOGIC INC | $16,626,000 | – | 473,667 | +100.0% | 7.53% | – |
| SIBN | Buy | SI BONE INC | $15,802,000 | +56.2% | 1,322,344 | +181.1% | 7.16% | +124.8% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $15,704,000 | -22.3% | 1,695,888 | +39.2% | 7.12% | +11.7% |
| CI | Sell | CIGNA CORP NEW | $12,656,000 | -23.3% | 71,428 | -11.5% | 5.74% | +10.3% |
| ANTM | Sell | ANTHEM INC | $9,842,000 | -60.3% | 43,351 | -47.2% | 4.46% | -42.9% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $9,511,000 | -53.3% | 94,096 | -30.9% | 4.31% | -32.9% |
| Buy | EVOLENT HEALTH INCnote 2.000%12/0 | $9,265,000 | -6.8% | 11,096,000 | +99900.0% | 4.20% | +34.0% | |
| ZTS | Buy | ZOETIS INCcl a | $8,853,000 | +66.4% | 75,222 | +87.1% | 4.01% | +139.4% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $7,632,000 | -70.4% | 136,925 | -65.9% | 3.46% | -57.4% |
| BDX | Sell | BECTON DICKINSON & CO | $7,123,000 | -54.2% | 31,000 | -45.7% | 3.23% | -34.1% |
| JNJ | New | JOHNSON & JOHNSON | $6,359,000 | – | 48,491 | +100.0% | 2.88% | – |
| MCK | Buy | MCKESSON CORP | $4,923,000 | +242.4% | 36,396 | +250.1% | 2.23% | +392.5% |
| RCM | Buy | R1 RCM INC | $4,407,000 | +38.0% | 484,801 | +97.1% | 2.00% | +98.5% |
| EHC | Sell | ENCOMPASS HEALTH CORP | $3,561,000 | -68.5% | 55,614 | -65.9% | 1.61% | -54.7% |
| AHCO | Buy | ADAPTHEALTH CORP | $3,534,000 | +91.8% | 220,896 | +31.6% | 1.60% | +175.6% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $3,330,000 | -81.8% | 26,344 | -75.6% | 1.51% | -73.8% |
| PRAH | Sell | PRA HEALTH SCIENCES INC | $3,223,000 | -50.8% | 38,817 | -34.2% | 1.46% | -29.2% |
| AVTR | New | AVANTOR INC | $3,115,000 | – | 249,382 | +100.0% | 1.41% | – |
| PRTA | Buy | PROTHENA CORP PLC | $2,739,000 | +57.1% | 255,949 | +132.4% | 1.24% | +126.0% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,724,000 | -29.9% | 2,619,187 | +27.5% | 1.23% | +0.8% |
| AMGN | New | AMGEN INC | $2,675,000 | – | 13,193 | +100.0% | 1.21% | – |
| HRC | Sell | HILL ROM HLDGS INC | $2,640,000 | -64.7% | 26,240 | -60.1% | 1.20% | -49.2% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $2,417,000 | – | 28,599 | +100.0% | 1.10% | – |
| TAK | New | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $2,370,000 | – | 156,120 | +100.0% | 1.07% | – |
| CNC | New | CENTENE CORP DEL | $2,269,000 | – | 38,196 | +100.0% | 1.03% | – |
| DVA | Buy | DAVITA INC | $2,066,000 | +129.3% | 27,164 | +126.3% | 0.94% | +229.6% |
| XRAY | Sell | DENTSPLY SIRONA INC | $2,044,000 | -36.3% | 52,645 | -7.2% | 0.93% | -8.4% |
| New | TRILLIUM THERAPEUTICS INC | $1,930,000 | – | 477,704 | +100.0% | 0.88% | – | |
| CRL | New | CHARLES RIV LABS INTL INC | $1,659,000 | – | 13,147 | +100.0% | 0.75% | – |
| Buy | SENSEONICS HLDGS INCnote 5.250% 2/0 | $1,483,000 | -0.7% | 1,500,000 | +99900.0% | 0.67% | +43.0% | |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $1,479,000 | -52.4% | 16,890 | -43.2% | 0.67% | -31.5% |
| ZGNX | New | ZOGENIX INC | $1,454,000 | – | 58,787 | +100.0% | 0.66% | – |
| INSM | New | INSMED INC | $1,192,000 | – | 74,365 | +100.0% | 0.54% | – |
| ATRC | New | ATRICURE INC | $1,124,000 | – | 33,453 | +100.0% | 0.51% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $905,000 | -65.7% | 40,732 | -69.8% | 0.41% | -50.7% |
| IQV | Sell | IQVIA HLDGS INC | $899,000 | -88.3% | 8,332 | -83.3% | 0.41% | -83.2% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $728,000 | -36.9% | 12,367 | +10.9% | 0.33% | -9.1% |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $696,000 | – | 87,676 | +100.0% | 0.32% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $615,000 | +908.2% | 255,308 | +890.0% | 0.28% | +1368.4% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $605,000 | -87.0% | 20,207 | -88.0% | 0.27% | -81.4% |
| FLDM | Sell | FLUIDIGM CORP DEL | $590,000 | -83.6% | 232,291 | -77.5% | 0.27% | -76.5% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $530,000 | -85.4% | 8,927 | -86.5% | 0.24% | -79.0% |
| MGNX | Sell | MACROGENICS INC | $510,000 | -61.9% | 87,703 | -28.6% | 0.23% | -45.1% |
| HCA | New | HCA HEALTHCARE INC | $509,000 | – | 5,666 | +100.0% | 0.23% | – |
| GNCA | Buy | GENOCEA BIOSCIENCES INC | $455,000 | -7.7% | 264,307 | +11.0% | 0.21% | +32.9% |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $435,000 | – | 159,826 | +100.0% | 0.20% | – |
| OVID | New | OVID THERAPEUTICS INC | $347,000 | – | 116,297 | +100.0% | 0.16% | – |
| PETS | New | PETMED EXPRESS INC | $287,000 | – | 9,964 | +100.0% | 0.13% | – |
| KDMN | New | KADMON HLDGS INC | $256,000 | – | 61,188 | +100.0% | 0.12% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INCcall | $0 | – | -376,200 | -100.0% | -0.03% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INcall | $0 | – | -47,400 | -100.0% | -0.03% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -677,086 | -100.0% | -0.05% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -13,768 | -100.0% | -0.10% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -11,669 | -100.0% | -0.11% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -32,666 | -100.0% | -0.11% | – |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -59,178 | -100.0% | -0.16% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -19,362 | -100.0% | -0.19% | – |
| NCNA | Exit | NUCANA PLCsponsored adr | $0 | – | -109,150 | -100.0% | -0.21% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -21,361 | -100.0% | -0.40% | – |
| LQDA | Exit | LIQUIDIA TECHNOLOGIES INC | $0 | – | -317,993 | -100.0% | -0.43% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -17,940 | -100.0% | -0.63% | – |
| SILK | Exit | SILK ROAD MEDICAL INC | $0 | – | -51,303 | -100.0% | -0.65% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -214,823 | -100.0% | -0.78% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -34,151 | -100.0% | -0.90% | – |
| MDRX | Exit | ALLSCRIPTS HEALTHCARE SOLUTN | $0 | – | -447,986 | -100.0% | -1.38% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -39,822 | -100.0% | -1.62% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -16,600 | -100.0% | -1.68% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -597,303 | -100.0% | -1.70% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -89,614 | -100.0% | -1.92% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -98,596 | -100.0% | -2.75% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -27,390 | -100.0% | -3.24% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -218,820 | -100.0% | -5.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.